classify xylazine as a Schedule III controlled substance, establish permissible uses, and to declare an emergency.
Bill status
signed
all 5 stages cleared
Introduction
Jan 2024
Committee Review
Feb 2024
House Passage
Jan 2024
Senate Passage
Feb 2024
Signed into Law
Feb 2024
Introduced Jan 9, 2024
Signed Feb 13, 2024
Floor votes · Senate Feb 5, 2024 · House Jan 17, 2024
How they voted
32–0
Passed · 2 other
Total votes 34
Feb 5, 2024
D
Democratic4
100% Yea
R
Republican30
93% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
12
Key actions
7
Committee
2
Feb 13, 2024
Signed into law
Signed by the Governor on 2024-02-13 H.J. 314
executive
Feb 7, 2024
Upper · Passed
Signed by the President S.J. 281
upper
Feb 6, 2024
Upper · Passed
Signed by the Speaker H.J. 273
upper
Feb 5, 2024
Upper · Passed
Senate Do Pass , Passed, YEAS 32, NAYS 0 S.J. 261
upper
Feb 2, 2024
Upper · Passed
Health and Human Services Do Pass , Passed, YEAS 6, NAYS 0
upper
Jan 18, 2024
Introduced
First read in Senate and referred to S.J. 108
upper
Jan 17, 2024
Lower · Passed
House of Representatives Do Pass , Passed, YEAS 69, NAYS 0 H.J. 78
lower
Jan 16, 2024
Lower · Passed
Health and Human Services Do Pass , Passed, YEAS 13, NAYS 0
lower
Jan 9, 2024
Introduced
First read in House and referred to H.J. 18
lower
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 1028
Scope: SD
Hi! I can help you understand HB 1028. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline